Judith Koliwer

Principal Consultant Cell and Gene Therapy • Körber

After her PhD on the genetic background of autism spectrum disorders, Judith was leading an academic research group, which analyzed the physiological role of proteins associated with cancer and epilepsy by using lenti and retroviral transduction for genetic modification of cell cultures. As leading scientist for BSL2, she supported the development of all virus-based projects of Bielefeld University. In 2019, Judith joined the MES Company Körber Pharma Software, where she works as principal consultant for cell and gene therapy projects. She works closely together with ATMP manufacturers supporting them in transitioning their manufacturing process from paper to a digital solution.

Also speaking

David Horna

Co-Founder & Chief Operating Officer • Aglaris

Alan Griffith

Vice President of Research • PureSpring Therapeutics

Michela Gabaldo

Head Alliance Management & Regulatory Affairs • Fondazione Telethon

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.